These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12877083)

  • 1. [Arteriosclerosis obliterans(ASO) in diabetic patients].
    Tanaka Y
    Nihon Rinsho; 2003 Jul; 61(7):1187-93. PubMed ID: 12877083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arteriosclerosis obliterans in Japanese diabetic patients.
    Matsuda A; Kuzuya T
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():569-73. PubMed ID: 6680533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and remission of diabetic nephropathy].
    Sugimoto T; Nakamura Y; Makino H
    Nihon Rinsho; 2003 Jul; 61(7):1167-71. PubMed ID: 12877079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical features and treatment of arteriosclerosis obliterans with diabetes.
    Tsushima N; Matsuo H; Hayashi T; Homma S
    Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arteriosclerosis obliterans (ASO)].
    Koshikawa M; Ikeda U
    Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes.
    Beach KW; Strandness DE
    Diabetes; 1980 Nov; 29(11):882-8. PubMed ID: 7429028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and survival in end-stage renal disease patients with arteriosclerosis obliterans.
    Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kawano Y
    Am J Nephrol; 2002; 22(5-6):422-8. PubMed ID: 12381939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and arteriosclerosis obliterans in patients with NIDDM.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Nov; 20(11):1738-43. PubMed ID: 9353618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
    George PB; Tobin KJ; Corpus RA; Devlin WH; O'Neill WW
    Am Heart J; 2001 Nov; 142(5):857-63. PubMed ID: 11685175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluations of double filtration plasma perfusion (DFPP) for arteriosclerosis obliterans (ASO) in maintenance hemodialysis patients].
    Chiba E
    Nihon Rinsho; 2004 May; 62 Suppl 5():603-6. PubMed ID: 15197993
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis obliterans in diabetes mellitus--concept and management].
    Ito M
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():329-35. PubMed ID: 12430249
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood pressure control and diabetic retinopathy].
    Kitano S
    Nihon Rinsho; 2003 Jul; 61(7):1172-4. PubMed ID: 12877080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive treatment of patients with diabetes and hypertension.
    Julius S; Majahalme S; Palatini P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):310S-316S. PubMed ID: 11721889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G; MacIsaac RJ
    Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
    Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Emrich I; Mancia G; Redon J; Schmieder RE; Sliwa K; Lehrke M; Marx N; Weber MA; Williams B; Yusuf S; Mann JFE
    J Hypertens; 2021 Apr; 39(4):766-774. PubMed ID: 33560052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.